SCIENTISTS in Scotland have made a “very exciting breakthrough” in the race to find a cure for motor neurone disease.
Researchers at the University of Edinburgh identified a key cause of the illness which could be combatted by repurposing drugs approved for other diseases.
There is no known cure for MND, a condition which stops signals from the brain reaching the muscles, damaging them over time. More than 1500 people in the UK are diagnosed with the disease every year.
The new study was carried out at the Euan MacDonald Centre for MND Research.
The team there discovered that the damage to nerve cells caused by MND could be repaired by improving the energy levels in mitochondria – the power supply to the motor neurons.
They found that in human stem cell models of MND, the axon – the long part of the motor neuron cell that connects to the muscle – was shorter than in healthy cells. The movement of the mitochondria, which travel up and down the axons, were also impaired.
The scientists showed that this was caused by a defective energy supply from the mitochondria and that by boosting the mitochondria, the axon reverted back to normal.
Dr Arpan Mehta, who led the study at Euan MacDonald Centre for MND research said: "The importance of the axon in motor nerve cells cannot be understated.
"Our data provides hope that by restoring the cell's energy source we can protect the axons and their connection to muscle from degeneration.
"Work is already under way to identify existing licensed drugs that can boost the mitochondria and repair the motor neurons. This will then pave the way to test them in clinical trials."
The study was welcomed by by charities including the foundation set up by Scots rugby legend Doddie Weir.
My Name'5 Doddie foundation described it as "a very exciting breakthrough".
The researchers used stem cells taken from people with the C9orf72 gene mutation that causes both MND and frontotemporal dementia.
They used the stem cells to generate motor neuron cells in the lab.
The study also used human post-mortem spinal cord tissue from people with MND.
Although the research focused on the people with the commonest genetic cause of MND, the researchers said they were hopeful the results would also apply to other forms of the disease.
The results of the study are now being used to look for existing drugs that boost mitochondrial function.
Craig Stockton, the chief executive of MND Scotland, also welcomed the news.
"We look forward to seeing if these positive results can be replicated for patients," he said.
"Once researchers have identified a drug they believe could have the desired effect, this treatment could then be fast-tracked for human trials using the pioneering MND-SMART clinical trial platform – into which MND Scotland has invested £1.5m.
"Researchers, clinicians, charities and supporters are all working hard to take us closer to finding a cure and by joining together we'll get to that day even sooner."
The study was funded by the Medical Research Council, Motor Neurone Disease Association, Euan MacDonald Centre for MND Research, My Name'5 Doddie Foundation, UK Dementia Research Institute and Anne Rowling Regenerative Neurology Clinic.
Why are you making commenting on The National only available to subscribers?
We know there are thousands of National readers who want to debate, argue and go back and forth in the comments section of our stories. We’ve got the most informed readers in Scotland, asking each other the big questions about the future of our country.
Unfortunately, though, these important debates are being spoiled by a vocal minority of trolls who aren’t really interested in the issues, try to derail the conversations, register under fake names, and post vile abuse.
So that’s why we’ve decided to make the ability to comment only available to our paying subscribers. That way, all the trolls who post abuse on our website will have to pay if they want to join the debate – and risk a permanent ban from the account that they subscribe with.
The conversation will go back to what it should be about – people who care passionately about the issues, but disagree constructively on what we should do about them. Let’s get that debate started!
Callum Baird, Editor of The National
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules hereLast Updated:
Report this comment Cancel